Current Protein Identity:P55201 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
2RS9 Solution structure of the bromodomain of human BRPF1 in complex with histone H4K5ac peptide Deposited 2011-12-08 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 633–740(108 aa) Fragment:Bromodomain, UNP residues 633-740
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6.5;288 K;Ionic strength (raw mmCIF value) 100;Pressure ambient
NMR sample composition 1.5 mM H4K5ac-1, 0.54 mM [U-99% 13C; U-99% 15N] Bromodomain-2, 90% H2O/10% D2O | 90% H2O/10% D2O
Resolution not provided
2X35 Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-01-21 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1076–1205(130 aa) Fragment:BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;20% PEG 3350, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5), 10 MM NACL
Resolution 2.00 Å R-free 0.236
2X4W Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1076–1205(130 aa) Fragment:RESIDUES 1076-1205
Not recorded FMT FORMIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;4M SODIUM FORMATE, 0.1M TRIS (PH 8.5), 0.01M NACL
Resolution 1.50 Å R-free 0.216
2X4X Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 1076–1205(130 aa) Fragment:BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;20% PEG3350, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5) 0.01M NACL
Resolution 1.85 Å R-free 0.239
2X4X Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1076–1205(130 aa) Fragment:BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;20% PEG3350, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5) 0.01M NACL
Resolution 1.85 Å R-free 0.239
2X4X Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 Assembly 3 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain G 1076–1205(130 aa) Fragment:BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;20% PEG3350, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5) 0.01M NACL
Resolution 1.85 Å R-free 0.239
2X4X Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 Assembly 4 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1076–1205(130 aa) Fragment:BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
Not recorded SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;20% PEG3350, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5) 0.01M NACL
Resolution 1.85 Å R-free 0.239
2X4Y Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain O 1076–1205(130 aa) Fragment:BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;30% PEG4K, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5), 0.01M NACL.
Resolution 1.70 Å R-free 0.227
2X4Y Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 1076–1205(130 aa) Fragment:BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
Not recorded SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;30% PEG4K, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5), 0.01M NACL.
Resolution 1.70 Å R-free 0.227
2X4Y Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 Assembly 3 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1076–1205(130 aa) Fragment:BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
Not recorded SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;30% PEG4K, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5), 0.01M NACL.
Resolution 1.70 Å R-free 0.227
2X4Y Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 Assembly 4 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain G 1076–1205(130 aa) Fragment:BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
Not recorded SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;30% PEG4K, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5), 0.01M NACL.
Resolution 1.70 Å R-free 0.227
2X4Y Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 Assembly 5 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain K 1076–1205(130 aa) Fragment:BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;30% PEG4K, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5), 0.01M NACL.
Resolution 1.70 Å R-free 0.227
2X4Y Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 Assembly 6 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain M 1076–1205(130 aa) Fragment:BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;30% PEG4K, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5), 0.01M NACL.
Resolution 1.70 Å R-free 0.227
2X4Y Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 Assembly 7 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 1076–1205(130 aa) Fragment:BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;30% PEG4K, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5), 0.01M NACL.
Resolution 1.70 Å R-free 0.227
2X4Y Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 Assembly 8 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1076–1205(130 aa) Fragment:BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
Not recorded SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;30% PEG4K, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5), 0.01M NACL.
Resolution 1.70 Å R-free 0.227
3L42 PWWP domain of human bromodomain and PHD finger containing protein 1 Deposited 2009-12-18 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1079–1207(129 aa) Fragment:UNP residues 1079-1207
Not recorded UNX UNKNOWN LIGAND × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 8.5;291 K;3.5M sodium formate, 0.1M TRIS-hydrochloride, pH 8.5, vapor diffusion, temperature 291K
X-ray crystallization conditions VAPOR DIFFUSION;pH 7.5;291 K;25% PEG3350, 0.1M ammonium sulfate, 0.1M HEPES, pH 7.5, vapor diffusion, temperature 291K
Resolution 1.30 Å R-free 0.233
3MO8 PWWP Domain of Human Bromodomain and PHD finger-containing protein 1 In Complex with Trimethylated H3K36 Peptide Deposited 2010-04-22 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1079–1207(129 aa) Fragment:UNP residues 1079-1207
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;3.5M sodium formate, 0.1M Tris-HCl pH8.5, H3K36me3 peptide, VAPOR DIFFUSION, SITTING DROP, temperature 293K
Resolution 1.69 Å R-free 0.207
4LC2 Crystal structure of the bromodomain of human BRPF1B Deposited 2013-06-21 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa) Fragment:unp residues 626-740
Not recorded NO3 NITRATE ION × 1 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.8;277 K;20% PEG3350 0.1 M bis tris propane, 10% ethylene glycol 0.15 M sodium nitrate, pH 7.8, VAPOR DIFFUSION, SITTING DROP, temperature 277K
Resolution 1.65 Å R-free 0.220
4QYD Crystal Structure of the human BRPF1 bromodomain in complex with a histone H4K12ac peptide Deposited 2014-07-24 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 629–742(114 aa) Fragment:bromodomain (UNP residues 629-742)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;277 K;0.1 M HEPES, pH 7.5, 10% w/v polyethylene glycol (PEG) 6,000, 5% v/v (+/-)-2-methyl-2,4-pentanediol (MPD), VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 1.94 Å R-free 0.213
4QYL Crystal Structure of the human BRPF1 bromodomain in complex with a histone H2AK5ac peptide Deposited 2014-07-24 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 629–742(114 aa) Fragment:bromodomain (UNP residues 629-742)
Not recorded SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;0.2 M NH4SO4, 0.1 M MES monohydrate, pH 6.5, 30% w/v polyethylene glycol monomethyl ether (PEG) 5000, 1% propylene glycol, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 1.80 Å R-free 0.253
4QYL Crystal Structure of the human BRPF1 bromodomain in complex with a histone H2AK5ac peptide Deposited 2014-07-24 Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 629–742(114 aa) Fragment:bromodomain (UNP residues 629-742)
Not recorded SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;0.2 M NH4SO4, 0.1 M MES monohydrate, pH 6.5, 30% w/v polyethylene glycol monomethyl ether (PEG) 5000, 1% propylene glycol, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 1.80 Å R-free 0.253
4QYL Crystal Structure of the human BRPF1 bromodomain in complex with a histone H2AK5ac peptide Deposited 2014-07-24 Assembly 3 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 629–742(114 aa) Fragment:bromodomain (UNP residues 629-742)
Not recorded SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;0.2 M NH4SO4, 0.1 M MES monohydrate, pH 6.5, 30% w/v polyethylene glycol monomethyl ether (PEG) 5000, 1% propylene glycol, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 1.80 Å R-free 0.253
4QYL Crystal Structure of the human BRPF1 bromodomain in complex with a histone H2AK5ac peptide Deposited 2014-07-24 Assembly 4 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 629–742(114 aa) Fragment:bromodomain (UNP residues 629-742)
Not recorded SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;0.2 M NH4SO4, 0.1 M MES monohydrate, pH 6.5, 30% w/v polyethylene glycol monomethyl ether (PEG) 5000, 1% propylene glycol, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 1.80 Å R-free 0.253
4UYE BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-2-oxo-6-(piperidin-1- yl)-2,3-dihydro-1H-1,3-benzodiazol-5-yl-2-methoxybenzamide Deposited 2014-08-30 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 622–738(117 aa) Fragment:BROMODOMAIN, UNP RESIDUES 622-738
Not recorded EDO 1,2-ETHANEDIOL × 1 9F9 N-[1,3-dimethyl-2-oxo-6-(piperidin-1-yl)-2,3-dihydro-1H-benzimidazol-5-yl]-2-methoxybenzamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6.5;0.1 M MES/IMIDAZOLE PH 6.5, 10% MORPHEUS DIVALENTS MPD_P1K_P3350
Resolution 1.65 Å R-free 0.201
4UYE BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-2-oxo-6-(piperidin-1- yl)-2,3-dihydro-1H-1,3-benzodiazol-5-yl-2-methoxybenzamide Deposited 2014-08-30 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 622–738(117 aa) Fragment:BROMODOMAIN, UNP RESIDUES 622-738
Not recorded 9F9 N-[1,3-dimethyl-2-oxo-6-(piperidin-1-yl)-2,3-dihydro-1H-benzimidazol-5-yl]-2-methoxybenzamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6.5;0.1 M MES/IMIDAZOLE PH 6.5, 10% MORPHEUS DIVALENTS MPD_P1K_P3350
Resolution 1.65 Å R-free 0.201
5C6S Human Bromodomain and PHD Finger Containing 1, PWWP domain in complex with XST005904a Deposited 2015-06-23 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1079–1207(129 aa) Fragment:PWWP domain (UNP residues 1079-1207)
Not recorded 4K8 isoquinoline-3-carboxylic acid × 1 CL CHLORIDE ION × 1 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1 UNX UNKNOWN LIGAND × 15 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;25% PEG 3350, 0.2M LiSO4, 0.1M HEPES pH7.5
Resolution 1.30 Å R-free 0.217
5C7N Crystal structure of the human BRPF1 bromodomain in complex with Bromosporine Deposited 2015-06-24 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa) Fragment:residues 626-740
Not recorded BMF Bromosporine × 1 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;20% PEG3350, 0.1 M sodium acetate, 0.15 M sodium nitrate, pH 5.5
Resolution 1.75 Å R-free 0.221
5C85 Crystal structure of the human BRPF1 bromodomain in complex with SEED1 Deposited 2015-06-25 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa)
Not recorded NO3 NITRATE ION × 1 4YO 6-bromo-3,4-dihydroquinoxalin-2(1H)-one × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Bis-Tris propane, pH6.5, 0.2 M sodium nitrate, 20%PEG33500
Resolution 1.70 Å R-free 0.226
5C87 Crystal structure of the human BRPF1 bromodomain in complex with SEED2 Deposited 2015-06-25 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa) Fragment:residues 626-740
Not recorded NO3 NITRATE ION × 1 4YS isoquinolin-1(2H)-one × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Bis-Tris propane, pH6.5, 0.2 M sodium nitrate, 20%PEG33500
Resolution 1.55 Å R-free 0.198
5C89 Crystal structure of the human BRPF1 bromodomain in complex with 917 Deposited 2015-06-25 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 627–740(114 aa)
Not recorded 4YT 1-ethyl-8-methoxy-5-methyl[1,2,4]triazolo[4,3-a]quinoline × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1M sodium acetate, pH 5.5, 0.15 M potassium thiocynate, 20% PEG3350
Resolution 1.65 Å R-free 0.200
5D7X Crystal structure of the human BRPF1 bromodomain in complex with XZ08 Deposited 2015-08-14 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa) Fragment:UNP residues 626-740
Not recorded NO3 NITRATE ION × 1 XZ8 4-(1-acetyl-1H-indol-3-yl)-5-methyl-1,2-dihydro-3H-pyrazol-3-one × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;0.1 M Bis-Tris Propane, pH6.5, 0.2M Sodium Nitrate, 20% PEG3350
Resolution 1.35 Å R-free 0.176
5DY7 Crystal structure of the human BRPF1 bromodomain in complex with SEED4 Deposited 2015-09-24 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa)
Not recorded 5GT 7-(trifluoromethyl)-3,4-dihydroquinoxalin-2(1H)-one × 1 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;0.1M Sodium Acetate, pH5.5, 0.15 M Sodium Nitrate, 20% PEG3350
Resolution 1.69 Å R-free 0.204
5DYA Crystal structure of the human BRPF1 bromodomain in complex with SEED5 Deposited 2015-09-24 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 625–740(116 aa) Fragment:UNP residues 625-740
Not recorded NO3 NITRATE ION × 1 5GV (2R)-2-ethyl-3-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxylic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;0.1M Sodium Acetate, pH5.5, 0.15 M Sodium Nitrate, 20% PEG3350
Resolution 1.65 Å R-free 0.214
5DYC Crystal structure of the human BRPF1 bromodomain in complex with SEED6 Deposited 2015-09-24 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 625–740(116 aa) Fragment:UNP residues 625-740
Not recorded NO3 NITRATE ION × 1 5GU 7-bromo-3,4-dihydroquinoxalin-2(1H)-one × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1M Sodium Acetate, pH5.5, 0.15 M Sodium Nitrate, 20% PEG3350
Resolution 1.65 Å R-free 0.235
5E3D Crystal structure of the human BRPF1 bromodomain in complex with SEED7 Deposited 2015-10-02 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa) Fragment:UNP residues 626-740
Not recorded 5JL 2,8-dithioxo-1,2,3,7,8,9-hexahydro-6H-purin-6-one × 1 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;0.1 M Sodium Acetate, pH5.5, 0.15 M Sodium Nitrate, 20% PEG3350
Resolution 1.71 Å R-free 0.222
5E3G Crystal structure of the human BRPF1 bromodomain in complex with SEED8 Deposited 2015-10-02 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa) Fragment:UNP residues 626-740
Not recorded 5JQ 2-thioxo-2,3,7,9-tetrahydro-1H-purine-6,8-dione × 1 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Sodium Acetate, pH 5.5, 0.15 M Sodium Nitrate, 20% PEG3350
Resolution 1.65 Å R-free 0.205
5EM3 Crystal structure of the human BRPF1 bromodomain in complex with SEED9 Deposited 2015-11-05 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa) Fragment:UNP residues 626-740
Not recorded 5Q0 quinolin-5-ol × 2 NO3 NITRATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Sodium-Acetate, pH5.5, 0.15 M Sodium Nitrate, 20% PEG3350
Resolution 1.40 Å R-free 0.188
5EPR Crystal structure of the human BRPF1 bromodomain in complex with SEED11 Deposited 2015-11-12 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa) Fragment:UNP residues 626-740
Not recorded 5QY (3~{S})-3-methyl-3,4-dihydro-1~{H}-quinoxalin-2-one × 1 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Sodium Acetate, pH5.5, 0.15 M Sodium Nitrate, 20% PEG3350
Resolution 1.65 Å R-free 0.220
5EPS Crystal structure of the human BRPF1 bromodomain in complex with SEED10 Deposited 2015-11-12 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 627–740(114 aa) Fragment:UNP residues 625-740
Not recorded 5QX 1-methyl-3,4-dihydroquinoxalin-2-one × 1 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;0.1 M Sodium Acetate, pH5.5, 0.15 M Sodium Nitrate, 20% PEG3350
Resolution 1.47 Å R-free 0.198
5EQ1 Crystal structure of the human BRPF1 bromodomain in complex with SEED12 Deposited 2015-11-12 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa) Fragment:UNP residues 626-740
Not recorded BEA 5-METHYL-1,2,4-TRIAZOLO[3,4-B]BENZOTHIAZOLE × 1 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium nitrate, 20% PEG3350
Resolution 1.55 Å R-free 0.194
5ERC X-ray crystal structure of BRPF1 PZP domain Deposited 2015-11-13 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 274–450(177 aa) Fragment:PZP domain (UNP residues 274-450)
Not recorded ZN ZINC ION × 5 CA CALCIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;0.2 M Calcium acetate, 0.1 M Imidazole pH 8.0, 10% PEG8000
Resolution 2.05 Å R-free 0.193
5ETB Crystal structure of the human BRPF1 bromodomain in complex with SEED13 Deposited 2015-11-17 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa) Fragment:UNP residues 626-740
Not recorded 5RO 1-(7-methyl-1~{H}-indol-3-yl)ethanone × 1 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium nitrate, 20% PEG3350
Resolution 1.33 Å R-free 0.187
5ETD Crystal structure of the human BRPF1 bromodomain in complex with SEED14 Deposited 2015-11-17 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa) Fragment:UNP residues 626-740
Not recorded 5RN 1-(1~{H}-indol-3-yl)ethanone × 1 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium nitrate, 20% PEG3350
Resolution 1.40 Å R-free 0.187
5EV9 Crystal structure of the human BRPF1 bromodomain in complex with SEED15 Deposited 2015-11-19 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa) Fragment:UNP residues 626-740
Not recorded 5SB ~{N}-[5-(1~{H}-pyrazol-4-yl)quinolin-8-yl]ethanamide × 1 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1M Sodium Acetate, pH5.5, 0.15 M Sodium Nitrate, 20% PEG3350
Resolution 1.45 Å R-free 0.221
5EVA Crystal structure of the human BRPF1 bromodomain in complex with SEED16 Deposited 2015-11-19 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa) Fragment:UNP residues 626-740
Not recorded 5S9 ~{N}-[2,4-bis(fluoranyl)phenyl]-2-methyl-pyrazole-3-carboxamide × 1 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium nitrate, 20% PEG3350
Resolution 1.45 Å R-free 0.198
5EWC Crystal structure of the human BRPF1 bromodomain in complex with SEED17 Deposited 2015-11-20 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa) Fragment:UNP residues 626-740
Not recorded 5SJ ethyl (2~{R})-2-methyl-3-oxidanylidene-2,4-dihydro-1~{H}-quinoxaline-6-carboxylate × 1 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1M Sodium Acetate, pH5.5, 0.15 M Sodium Nitrate, 20% PEG3350
Resolution 1.75 Å R-free 0.211
5EWD Crystal structure of the human BRPF1 bromodomain in complex with SEED18 Deposited 2015-11-20 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa) Fragment:UNP residues 626-740
Not recorded 5SH 4-phenylpyridine × 1 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1M Sodium Acetate, pH5.5, 0.15 M Sodium Nitrate, 20% PEG3350
Resolution 1.58 Å R-free 0.226
5EWH Crystal structure of the human BRPF1 bromodomain in complex with SEED19 Deposited 2015-11-20 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa) Fragment:UNP residues 626-740
Not recorded 5SG isoquinolin-5-ol × 1 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1M Sodium Acetate, pH5.5, 0.15 M Sodium Nitrate, 20% PEG3350
Resolution 1.63 Å R-free 0.213
5EWV Crystal structure of the human BRPF1 bromodomain in complex with SEED20 Deposited 2015-11-21 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa) Fragment:UNP residues 626-740
Not recorded 5SN 1,5-dimethyl-[1,2,4]triazolo[4,3-a]quinoline × 1 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium nitrate, 20% PEG3350
Resolution 1.67 Å R-free 0.221
5EWW Crystal structure of the human BRPF1 bromodomain in complex with SEED21 Deposited 2015-11-21 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa) Fragment:UNP residues 626-740#
Not recorded 5SK ~{N}-[(2~{R})-butan-2-yl]-1-methyl-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine × 1 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium nitrate, 20% PEG3350
Resolution 1.73 Å R-free 0.210
5FFV Crystal structure of the bromodomain of human BRPF1 in complex with H3K14ac histone peptide Deposited 2015-12-19 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 626–740(115 aa) Fragment:UNP residues 626-740
Not recorded EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.5;277.15 K;25% PEG3350, 0.2 M MgCl2, 0.1 M bis-tris pH 5.5
Resolution 1.30 Å R-free 0.206
5FFV Crystal structure of the bromodomain of human BRPF1 in complex with H3K14ac histone peptide Deposited 2015-12-19 Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 626–740(115 aa) Fragment:UNP residues 626-740
Not recorded EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.5;277.15 K;25% PEG3350, 0.2 M MgCl2, 0.1 M bis-tris pH 5.5
Resolution 1.30 Å R-free 0.206
5FFW Crystal structure of the bromodomain of human BRPF1 in complex with H4K5acK8ac histone peptide Deposited 2015-12-19 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 626–740(115 aa) Fragment:UNP residues 626-740
Chain B 626–740(115 aa) Fragment:UNP residues 626-740
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.5;277.15 K;0.2 M NaCl, 25% PEG3350, 0.1 M Hepes pH 7.5
Resolution 1.50 Å R-free 0.243
5FFY Crystal structure of the bromodomain of human BRPF1 in complex with a benzimidazole ligand Deposited 2015-12-19 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa) Fragment:UNP residues 626-740
Not recorded 5XD 4-ethyl-~{N}-(6-methoxy-1,3-dimethyl-2-oxidanylidene-benzimidazol-5-yl)benzenesulfonamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 9;277.15 K;0.1 M bis tris propane pH 9, 10% ethylene glycol, 0.15 M sodium nitrate
Resolution 1.55 Å R-free 0.213
5FG4 Crystal structure of the bromodomain of human BRPF1 in complex with OF-1 chemical probe Deposited 2015-12-20 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa)
Not recorded 5XE 4-bromanyl-~{N}-(6-methoxy-1,3-dimethyl-2-oxidanylidene-benzimidazol-5-yl)-2-methyl-benzenesulfonamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.4;277.15 K;25% PEG3350, 0.1M bis-tris propane pH 7.4, 5% ethyleneglycol, 0.15M sodium nitrate
Resolution 1.65 Å R-free 0.254
5FG5 Crystal structure of the bromodomain of human BRPF1 in complex with PFI-4 chemical probe Deposited 2015-12-20 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa)
Not recorded 5XF ~{N}-(1,3-dimethyl-2-oxidanylidene-6-pyrrolidin-1-yl-benzimidazol-5-yl)-2-methoxy-benzamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.5;277.15 K;15% PEG3350, 0.25 M sodium nitrate
Resolution 1.50 Å R-free 0.186
5FG5 Crystal structure of the bromodomain of human BRPF1 in complex with PFI-4 chemical probe Deposited 2015-12-20 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 626–740(115 aa)
Not recorded 5XF ~{N}-(1,3-dimethyl-2-oxidanylidene-6-pyrrolidin-1-yl-benzimidazol-5-yl)-2-methoxy-benzamide × 1 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.5;277.15 K;15% PEG3350, 0.25 M sodium nitrate
Resolution 1.50 Å R-free 0.186
5G4R BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-6-2R-2- methylpiperazin-1-yl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl-2- methoxybenzamide Deposited 2016-05-16 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 622–738(117 aa) Fragment:BROMODOMAIN OF BRPF1, UNP RESIDUES 622-738
Not recorded LF1 N-[1,3-dimethyl-6-[(2R)-2-methylpiperazin-1-yl]-2-oxidanylidene-benzimidazol-5-yl]-2-methoxy-benzamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;30% P550MME_P20K, 0.1M BUFFER 3, PH8.5, 10% ETHYLENE GLYCOLS
Resolution 1.96 Å R-free 0.240
5G4R BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-6-2R-2- methylpiperazin-1-yl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl-2- methoxybenzamide Deposited 2016-05-16 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 622–738(117 aa) Fragment:BROMODOMAIN OF BRPF1, UNP RESIDUES 622-738
Not recorded LF1 N-[1,3-dimethyl-6-[(2R)-2-methylpiperazin-1-yl]-2-oxidanylidene-benzimidazol-5-yl]-2-methoxy-benzamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;30% P550MME_P20K, 0.1M BUFFER 3, PH8.5, 10% ETHYLENE GLYCOLS
Resolution 1.96 Å R-free 0.240
5G4R BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-6-2R-2- methylpiperazin-1-yl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl-2- methoxybenzamide Deposited 2016-05-16 Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain C 622–738(117 aa) Fragment:BROMODOMAIN OF BRPF1, UNP RESIDUES 622-738
Not recorded LF1 N-[1,3-dimethyl-6-[(2R)-2-methylpiperazin-1-yl]-2-oxidanylidene-benzimidazol-5-yl]-2-methoxy-benzamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;30% P550MME_P20K, 0.1M BUFFER 3, PH8.5, 10% ETHYLENE GLYCOLS
Resolution 1.96 Å R-free 0.240
5G4R BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-6-2R-2- methylpiperazin-1-yl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl-2- methoxybenzamide Deposited 2016-05-16 Assembly 4 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain D 622–738(117 aa) Fragment:BROMODOMAIN OF BRPF1, UNP RESIDUES 622-738
Not recorded LF1 N-[1,3-dimethyl-6-[(2R)-2-methylpiperazin-1-yl]-2-oxidanylidene-benzimidazol-5-yl]-2-methoxy-benzamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;30% P550MME_P20K, 0.1M BUFFER 3, PH8.5, 10% ETHYLENE GLYCOLS
Resolution 1.96 Å R-free 0.240
5G4S BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-6-2R-2- methylpiperazin-1-yl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl-N- ethyl-2-methoxybenzamide Deposited 2016-05-16 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 624–738(115 aa) Fragment:BROMODOMAIN OF BRPF1, UNP RESIDUES 624-738
Not recorded 8VI N-[1,3-dimethyl-6-[(2R)-2-methylpiperazin-1-yl]-2-oxidanylidene-benzimidazol-5-yl]-N-ethyl-2-methoxy-benzamide × 1 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6.5;0.1M MORPHEUS BUFFER 1, PH 6.5 37.5% MPD_P1K_P3350 10% MORPHEUS NITRATE-PHOSPHATE-SULPHATE
Resolution 1.60 Å R-free 0.194
5MWG Crystal structure of the human BRPF1 bromodomain in complex with BZ091 Deposited 2017-01-18 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa)
Not recorded WGX ~{N}-[1,4-dimethyl-2,3-bis(oxidanylidene)-7-piperidin-1-yl-quinoxalin-6-yl]-5,6,7,8-tetrahydronaphthalene-2-sulfonamide × 1 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium Nitrate, 20% PEG3350
Resolution 1.50 Å R-free 0.227
5MWG Crystal structure of the human BRPF1 bromodomain in complex with BZ091 Deposited 2017-01-18 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 626–740(115 aa)
Not recorded WGX ~{N}-[1,4-dimethyl-2,3-bis(oxidanylidene)-7-piperidin-1-yl-quinoxalin-6-yl]-5,6,7,8-tetrahydronaphthalene-2-sulfonamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium Nitrate, 20% PEG3350
Resolution 1.50 Å R-free 0.227
5MWH Crystal structure of the human BRPF1 bromodomain in complex with BZ089 Deposited 2017-01-18 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa)
Not recorded UWX ~{N}-[1,4-dimethyl-7-morpholin-4-yl-2,3-bis(oxidanylidene)quinoxalin-6-yl]-4-(2-methylpropyl)benzenesulfonamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium nitrate, 20% PEG3350
Resolution 1.65 Å R-free 0.226
5MWH Crystal structure of the human BRPF1 bromodomain in complex with BZ089 Deposited 2017-01-18 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 626–740(115 aa)
Not recorded UWX ~{N}-[1,4-dimethyl-7-morpholin-4-yl-2,3-bis(oxidanylidene)quinoxalin-6-yl]-4-(2-methylpropyl)benzenesulfonamide × 1 NO3 NITRATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium nitrate, 20% PEG3350
Resolution 1.65 Å R-free 0.226
5MWZ Crystal structure of the human BRPF1 bromodomain in complex with BZ073 Deposited 2017-01-20 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa)
Not recorded KGU ~{N}-[1,4-diethyl-2,3-bis(oxidanylidene)-7-piperidin-1-yl-quinoxalin-6-yl]-2-(4-methylpiperazin-1-yl)ethanamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;277 K;0.1 M Bis-Tris Propane pH7.4, 25% PEG3350, 5% EG, 0.15 M NaNO3
Resolution 1.25 Å R-free 0.181
5MYG Crystal structure of the bromodomain of human BRPF1 in complex with NI-57 chemical probe Deposited 2017-01-26 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa)
Not recorded LS8 4-cyano-~{N}-(1,3-dimethyl-2-oxidanylidene-quinolin-6-yl)-2-methoxy-benzenesulfonamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.1 M ammonium acetate, 17% PEG 10K, 0.1 M bis-tris pH 5.5
Resolution 2.30 Å R-free 0.307
5MYG Crystal structure of the bromodomain of human BRPF1 in complex with NI-57 chemical probe Deposited 2017-01-26 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 626–740(115 aa)
Not recorded LS8 4-cyano-~{N}-(1,3-dimethyl-2-oxidanylidene-quinolin-6-yl)-2-methoxy-benzenesulfonamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.1 M ammonium acetate, 17% PEG 10K, 0.1 M bis-tris pH 5.5
Resolution 2.30 Å R-free 0.307
5MYG Crystal structure of the bromodomain of human BRPF1 in complex with NI-57 chemical probe Deposited 2017-01-26 Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain C 626–740(115 aa)
Not recorded LS8 4-cyano-~{N}-(1,3-dimethyl-2-oxidanylidene-quinolin-6-yl)-2-methoxy-benzenesulfonamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.1 M ammonium acetate, 17% PEG 10K, 0.1 M bis-tris pH 5.5
Resolution 2.30 Å R-free 0.307
5MYG Crystal structure of the bromodomain of human BRPF1 in complex with NI-57 chemical probe Deposited 2017-01-26 Assembly 4 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain D 626–740(115 aa)
Not recorded LS8 4-cyano-~{N}-(1,3-dimethyl-2-oxidanylidene-quinolin-6-yl)-2-methoxy-benzenesulfonamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.1 M ammonium acetate, 17% PEG 10K, 0.1 M bis-tris pH 5.5
Resolution 2.30 Å R-free 0.307
5O4S Crystal structure of the human BRPF1 bromodomain in complex with BZ135 Deposited 2017-05-30 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa)
Not recorded 9KW ~{N}-[1,4-dimethyl-7-morpholin-4-yl-2,3-bis(oxidanylidene)quinoxalin-6-yl]-5,6,7,8-tetrahydronaphthalene-2-sulfonamide × 1 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;297 K;0.1 M Bis-tris propane, pH6.5, 0.15 M Sodium Nitrate, 20% PEG3350
Resolution 1.75 Å R-free 0.221
5O4S Crystal structure of the human BRPF1 bromodomain in complex with BZ135 Deposited 2017-05-30 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 626–740(115 aa)
Not recorded 9KW ~{N}-[1,4-dimethyl-7-morpholin-4-yl-2,3-bis(oxidanylidene)quinoxalin-6-yl]-5,6,7,8-tetrahydronaphthalene-2-sulfonamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;297 K;0.1 M Bis-tris propane, pH6.5, 0.15 M Sodium Nitrate, 20% PEG3350
Resolution 1.75 Å R-free 0.221
5O4T Crystal structure of the human BRPF1 bromodomain in complex with BZ061 Deposited 2017-05-30 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa)
Not recorded 9KT 1,4-dimethylquinoxaline-2,3-dione × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium nitrate, 20% PEG3350
Resolution 1.50 Å R-free 0.212
5O55 Crystal structure of the human BRPF1 bromodomain in complex with BZ047 Deposited 2017-05-31 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa) Fragment:UNP residues 626-740
Not recorded NO3 NITRATE ION × 1 9L5 ~{N}-[(1~{S})-1-(1,5-dimethylpyrazol-4-yl)ethyl]-1-ethyl-3-methyl-2-oxidanylidene-quinoxaline-6-carboxamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Bis-tris propane, pH6.5, 0.15 M Sodium Nitrate, 20% PEG3350
Resolution 1.45 Å R-free 0.201
5O5A Crystal structure of the human BRPF1 bromodomain in complex with BZ032 Deposited 2017-06-01 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa)
Not recorded NO3 NITRATE ION × 1 9LN 1-ethyl-~{N}-methyl-2,3-bis(oxidanylidene)-~{N}-[(1-phenylpyrazol-4-yl)methyl]-4~{H}-quinoxaline-6-carboxamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium nitrate, 20% PEG3350
Resolution 1.60 Å R-free 0.202
5O5F Crystal structure of the human BRPF1 bromodomain in complex with BZ038 Deposited 2017-06-01 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa)
Not recorded 9LT 1-ethyl-~{N}-[(~{R})-(3-fluorophenyl)-(1-methylimidazol-2-yl)methyl]-2,3-bis(oxidanylidene)-4~{H}-quinoxaline-6-carboxamide × 1 NO3 NITRATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium Nitrate, 20% PEG3350
Resolution 1.30 Å R-free 0.188
5O5H Crystal structure of the human BRPF1 bromodomain in complex with BZ053 Deposited 2017-06-01 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa)
Not recorded 9LK ~{N}-[6-(4-chloranylphenoxy)pyridin-3-yl]-2,4-dimethyl-1,3-oxazole-5-carboxamide × 2 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Bis-Tris Propane, pH6.5, 0.2 M Sodium Nitrate, 20% PEG3350
Resolution 1.85 Å R-free 0.235
5OV8 Crystal structure of the human BRPF1 bromodomain in complex with BZ097 Deposited 2017-08-28 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa)
Not recorded AXN ~{N}-[1,4-dimethyl-2,3-bis(oxidanylidene)-7-pyrrolidin-1-yl-quinoxalin-6-yl]-4-(2-methylpropyl)benzenesulfonamide × 1 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Bis-Tris Propane pH9, 10% EG, 0.15M NaNO3, 25% PEG3350
Resolution 1.80 Å R-free 0.244
5OV8 Crystal structure of the human BRPF1 bromodomain in complex with BZ097 Deposited 2017-08-28 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 626–740(115 aa)
Not recorded AXN ~{N}-[1,4-dimethyl-2,3-bis(oxidanylidene)-7-pyrrolidin-1-yl-quinoxalin-6-yl]-4-(2-methylpropyl)benzenesulfonamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Bis-Tris Propane pH9, 10% EG, 0.15M NaNO3, 25% PEG3350
Resolution 1.80 Å R-free 0.244
5OWA Crystal structure of the human BRPF1 bromodomain in complex with BZ054 Deposited 2017-08-31 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa)
Not recorded B0H ~{N}-[4-[[(3~{S},5~{R})-3,5-dimethylpiperidin-1-yl]methyl]-1,3-thiazol-2-yl]-2,4-dimethyl-1,3-oxazole-5-carboxamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;277 K;0.2 M MgCl2, 20% PEG3350
Resolution 1.95 Å R-free 0.268
5OWA Crystal structure of the human BRPF1 bromodomain in complex with BZ054 Deposited 2017-08-31 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 626–740(115 aa)
Not recorded B0H ~{N}-[4-[[(3~{S},5~{R})-3,5-dimethylpiperidin-1-yl]methyl]-1,3-thiazol-2-yl]-2,4-dimethyl-1,3-oxazole-5-carboxamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;277 K;0.2 M MgCl2, 20% PEG3350
Resolution 1.95 Å R-free 0.268
5OWA Crystal structure of the human BRPF1 bromodomain in complex with BZ054 Deposited 2017-08-31 Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain C 626–740(115 aa)
Not recorded B0H ~{N}-[4-[[(3~{S},5~{R})-3,5-dimethylpiperidin-1-yl]methyl]-1,3-thiazol-2-yl]-2,4-dimethyl-1,3-oxazole-5-carboxamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;277 K;0.2 M MgCl2, 20% PEG3350
Resolution 1.95 Å R-free 0.268
5OWA Crystal structure of the human BRPF1 bromodomain in complex with BZ054 Deposited 2017-08-31 Assembly 4 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain D 626–740(115 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;277 K;0.2 M MgCl2, 20% PEG3350
Resolution 1.95 Å R-free 0.268
5OWB Crystal structure of the human BRPF1 bromodomain in complex with DSPBP1004 Deposited 2017-08-31 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa)
Not recorded NO3 NITRATE ION × 1 AYW 4-methyl-6-oxidanyl-1-benzofuran-3-one × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1M Sodium Acetate, pH5.5, 0.15 M Sodium Nitrate, 20% PEG3350
Resolution 1.65 Å R-free 0.204
5OWE Crystal structure of the human BRPF1 bromodomain in complex with DSPBP1010 Deposited 2017-08-31 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa)
Not recorded B0E 1,3-bis(oxidanyl)benzo[c]chromen-6-one × 1 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium nitrate, 20% PEG3350
Resolution 1.70 Å R-free 0.213
5T4U Crystal structure of the bromodomain of human BRPF1 in complex with a quinolinone ligand Deposited 2016-08-30 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 627–740(114 aa)
Not recorded NO3 NITRATE ION × 1 12Q 1-METHYLQUINOLIN-2(1H)-ONE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.5;277.15 K;20 % PEG3350, 0.2 M ammonium nitrate
Resolution 1.50 Å R-free 0.231
5T4V Crystal structure of the bromodomain of human BRPF1 in complex with NI-48 ligand Deposited 2016-08-30 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 627–740(114 aa)
Not recorded N48 4-cyano-N-(7-methoxy-1,4-dimethyl-2-oxo-1,2-dihydroquinolin-6-yl)benzene-1-sulfonamide × 1 EDO 1,2-ETHANEDIOL × 1 FMT FORMIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.5;277.15 K;0.1 m bis-tris propane pH 8.5, 0.2 M sodium formate, 20% PEG 3350, 10% ethylene glycol
Resolution 1.65 Å R-free 0.250
6EKQ Crystal structure of the human BRPF1 bromodomain complexed with BZ054 in space group C2 Deposited 2017-09-26 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa)
Not recorded B0H ~{N}-[4-[[(3~{S},5~{R})-3,5-dimethylpiperidin-1-yl]methyl]-1,3-thiazol-2-yl]-2,4-dimethyl-1,3-oxazole-5-carboxamide × 1 NO3 NITRATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Bis-Tris Propane pH9, 10% EG, 0.15M NaNO3, 25% PEG3350
Resolution 1.65 Å R-free 0.182
6EKQ Crystal structure of the human BRPF1 bromodomain complexed with BZ054 in space group C2 Deposited 2017-09-26 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 626–740(115 aa)
Not recorded B0H ~{N}-[4-[[(3~{S},5~{R})-3,5-dimethylpiperidin-1-yl]methyl]-1,3-thiazol-2-yl]-2,4-dimethyl-1,3-oxazole-5-carboxamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M Bis-Tris Propane pH9, 10% EG, 0.15M NaNO3, 25% PEG3350
Resolution 1.65 Å R-free 0.182
6U04 Crystal structure of human BRPF1 PZP bound to histone H3 tail Deposited 2019-08-13 Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 271–454(184 aa)
Not recorded PR PRASEODYMIUM ION × 1 ZN ZINC ION × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8.5;291.15 K;0.2 M Lithium sulfate, 0.1 M Tris-HCl pH 8.5, 40% (v/v) PEG400, and 0.01M Praseodymium(III) acetate hydrate
Resolution 2.20 Å R-free 0.208
7C4I High resolution structure of BRPF1 Bromo Domain from Biortus Deposited 2020-05-18 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa)
Not recorded K POTASSIUM ION × 4 GOL GLYCEROL × 6 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M Potassium fluoride, 20 %(w/v) PEG 3350
Resolution 1.37 Å R-free 0.194
8QAZ Crystal Structure of BRPF1 bromodomain in complex with acetyl-pyrrole derivative compound 3 Deposited 2023-08-23 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa)
Mutation:bromodomain (residues 626-740) QA5 2-[4-[4-ethanoyl-5-methyl-3-(3-methylbutyl)-1~{H}-pyrrol-2-yl]-1,3-thiazol-2-yl]guanidine × 1 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.18 M sodium nitrate, 30% PEG 3350, 5% ethylene glycol
Resolution 1.40 Å R-free 0.196
8QB0 Crystal Structure of BRPF1 bromodomain in complex with acetyl-pyrrole derivative compound 2 Deposited 2023-08-23 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa)
Mutation:bromodomain (residues 626-740) Q9U 2-[4-(3,6,6-trimethyl-4-oxidanylidene-5,7-dihydro-2~{H}-isoindol-1-yl)-1,3-thiazol-2-yl]guanidine × 1 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.18 M sodium nitrate, 30% PEG 3350, 5% ethylene glycol
Resolution 1.45 Å R-free 0.208
8QB2 Crystal Structure of BRPF1 bromodomain in complex with acetyl-pyrrole derivative compound 79 Deposited 2023-08-24 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 626–740(115 aa)
Mutation:bromodomain (residues 626-740) GKI 1-[2-methyl-4-(3-methylbutyl)-5-(2-piperazin-1-yl-1,3-thiazol-4-yl)-1~{H}-pyrrol-3-yl]ethanone × 1 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.5;277 K;0.18 M sodium nitrate, 30% PEG 3350
Resolution 1.42 Å R-free 0.196